18 marzo 2015
A groundbreaking new triple combination therapy shows promising signs of more effectively controlling advanced melanoma than previous BRAF + MEK inhibitor or BRAF inhibitor + immunotherapy combos alone, and with increased immune response and fewer side effects.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/VV_g6xqEmOo/150318144334.htm
